Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'

Landegren, Nils ; Rosen, Lindsey B. ; Freyhult, Eva ; Eriksson, Daniel ; Fall, Tove LU ; Smith, Gustav LU ; Ferre, Elise M.N. ; Brodin, Petter ; Sharon, Donald and Snyder, Michael , et al. (2019) In eLife 8.
Abstract

The AIRE gene plays a key role in the development of central immune tolerance by promoting thymic presentation of tissue-specific molecules. Patients with AIRE-deficiency develop multiple autoimmune manifestations and display autoantibodies against the affected tissues. In 2016 it was reported that: i) the spectrum of autoantibodies in patients with AIRE-deficiency is much broader than previously appreciated; ii) neutralizing autoantibodies to type I interferons (IFNs) could provide protection against type 1 diabetes in these patients (Meyer et al., 2016). We attempted to replicate these new findings using a similar experimental approach in an independent patient cohort, and found no evidence for either conclusion.

Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
APS1/APECED, autoantibody, autoantigen, human, human biology, immune tolerance, immunology, inflammation, medicine, type 1 diabetes
in
eLife
volume
8
article number
e43578
publisher
eLife Sciences Publications
external identifiers
  • scopus:85068819205
  • pmid:31244471
ISSN
2050-084X
DOI
10.7554/eLife.43578
language
English
LU publication?
yes
id
8c5df12c-1262-404a-95f4-304007b5d2ee
date added to LUP
2019-07-23 14:30:23
date last changed
2024-04-16 16:49:04
@article{8c5df12c-1262-404a-95f4-304007b5d2ee,
  abstract     = {{<p>The AIRE gene plays a key role in the development of central immune tolerance by promoting thymic presentation of tissue-specific molecules. Patients with AIRE-deficiency develop multiple autoimmune manifestations and display autoantibodies against the affected tissues. In 2016 it was reported that: i) the spectrum of autoantibodies in patients with AIRE-deficiency is much broader than previously appreciated; ii) neutralizing autoantibodies to type I interferons (IFNs) could provide protection against type 1 diabetes in these patients (Meyer et al., 2016). We attempted to replicate these new findings using a similar experimental approach in an independent patient cohort, and found no evidence for either conclusion.</p>}},
  author       = {{Landegren, Nils and Rosen, Lindsey B. and Freyhult, Eva and Eriksson, Daniel and Fall, Tove and Smith, Gustav and Ferre, Elise M.N. and Brodin, Petter and Sharon, Donald and Snyder, Michael and Lionakis, Michail and Anderson, Mark and Kämpe, Olle}},
  issn         = {{2050-084X}},
  keywords     = {{APS1/APECED; autoantibody; autoantigen; human; human biology; immune tolerance; immunology; inflammation; medicine; type 1 diabetes}},
  language     = {{eng}},
  month        = {{06}},
  publisher    = {{eLife Sciences Publications}},
  series       = {{eLife}},
  title        = {{Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'}},
  url          = {{http://dx.doi.org/10.7554/eLife.43578}},
  doi          = {{10.7554/eLife.43578}},
  volume       = {{8}},
  year         = {{2019}},
}